Aprea Therapeutics, Inc.

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: US03836J2015

USD

1.06

0.04 (3.92%)

Dec 04

NAS

Click here to see other stocks

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Lisata Therapeutics, Inc.

Oncternal Therapeutics, Inc.

Acorda Therapeutics, Inc.

Cosmos Health, Inc.

NanoViricides, Inc.

Virios Therapeutics, Inc.

Aprea Therapeutics, Inc.

Acurx Pharmaceuticals, Inc.

Azitra, Inc.

Galecto, Inc.

Hepion Pharmaceuticals, Inc.

Why is Aprea Therapeutics, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is Aprea Therapeutics, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Aprea Therapeutics, Inc.

-66.03%

-1.00

72.56%

S&P 500

13.22%

0.61

20.17%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

12.97%

EBIT Growth (5y)

10.87%

EBIT to Interest (avg)

-25.29

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.14

Sales to Capital Employed (avg)

0.05

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

41.93%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.57

EV to EBIT

0.63

EV to EBITDA

0.63

EV to Capital Employed

3.97

EV to Sales

-7.47

PEG Ratio

Dividend Yield

ROCE (Latest)

631.77%

ROE (Latest)

-83.51%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

No Trend

Mildly Bearish

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company

OPERATING CASH FLOW(Y)

Highest at USD -12.93 MM

NET PROFIT(HY)

Higher at USD -7.17 MM

-11What is not working for the Company

NET SALES(HY)

At USD 0.28 MM has Grown at -70.22%

ROCE(HY)

Lowest at -67.54%

CASH AND EQV(HY)

Lowest at USD 35.81 MM

Here's what is working for Aprea Therapeutics, Inc.

Operating Cash Flow

Highest at USD -12.93 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Net Profit

Higher at USD -7.17 MM

than preceding 12 month period ended Jun 2025

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Here's what is not working for Aprea Therapeutics, Inc.

Net Sales

At USD 0.28 MM has Grown at -70.22%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very negative

Net Sales (USD MM)

Cash and Eqv

Lowest at USD 35.81 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents